The largest and most diverse study to date of epilepsy's genetic factors has revealed new potential targets for treatment, ...

WAKING groggily from a seizure, single Kerry Tadgell, 35, from Kent, felt like she was trapped in a horrifying bubble. She ...

More than three million Americans are diagnosed with epilepsy, and roughly a third of them cannot get relief from medications ...

Epi25 collects information from patients with various types of epilepsy, from severe types known as developmental and ...

The epilepsy medication sodium valproate is linked to developmental problems in fetuses, but lab studies may now have found a ...

Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) are working on a therapy that holds potential in treating patients with epilepsy, a neurological ...

The research work began in 2021, when the team was approached by the family of an infant who suffered from multiple generalised seizures that were resistant to multiple medications and conventional ...

Charlotte, from Co Tyrone, started campaigning for a change in the law after her son’s prescription cannabis was seized six ...

Lamotrigine extended-release tablets have an estimated market size of $163 million, as per data for twelve months ending June ...

Alembic has a cumulative total of 216 ANDA approvals (188 final approvals and 28 tentative approvals) from USFDA.

Bright Minds Biosciences will present scientific posters about various programs in development, including BMB-101, BMB-201 and BMB-202Bright ...

The approved ANDA is therapeutically equivalent to GlaxoSmithKline LLC's Lamictal XR extended-release tablets in strength of ...